Shares of Intellia Therapeutics (NASDAQ:NTLA) were up over 10% on Monday, after Wolfe Research upgraded the company to Outperform from Peer Perform.
Analyst Andy Chen said the enterprise value of the company is currently perceived to be nearly zero, indicating a
Intellia Therapeutics shares up after Wolfe upgrade
Recommended For You
More Trending News
About NTLA Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| NTLA | - | - |
| Intellia Therapeutics, Inc. | ||